» Articles » PMID: 32093169

Preeclampsia: The Interplay Between Oxygen-Sensitive MiRNAs and Erythropoietin

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Feb 26
PMID 32093169
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in the oxygen partial pressure caused by a violation of uteroplacental perfusion are considered a powerful inducer of a cascade of reactions leading to the clinical manifestation of preeclampsia (PE). At the same time, the induction of oxygen-dependent molecule expression, in particular, miRNA and erythropoietin, is modulated. Therefore, the focus of our study was aimed at estimating the miRNA expression profile of placental tissue and blood plasma in pregnant women with preeclampsia using deep sequencing and quantitative RT-PCR, as well as determining the concentration of erythropoietin. The expression of miR-27b-3p, miR-92b-3p, miR-125b-5p, miR-181a-5p, and miR-186-5p, as regulated by hypoxia/reoxygenation, was significantly increased in blood plasma during early-onset preeclampsia. The possibility of detecting early PE according to the logistic regression model (miR-92b-3p, miR-125b-5p, and miR-181a-5p (AUC = 0.91)) was evaluated. Furthermore, the erythropoietin level, which is regulated by miR-125b-5p, was significantly increased. According to PANTHER14.1, the participation of these miRNAs in the regulation of pathways, such as the hypoxia's response via HIF activation, oxidative stress response, angiogenesis, and the VEGF signaling pathway, were determined.

Citing Articles

Circulating Non-coding RNAs and Exosomes: Liquid Biopsies for Monitoring Preeclampsia.

Li N, Gu Y, Tang J, Li Y, Chen D, Xu Z Methods Mol Biol. 2023; 2695:263-277.

PMID: 37450125 DOI: 10.1007/978-1-0716-3346-5_18.


Long noncoding RNA WT1-AS regulates trophoblast proliferation, migration, and invasion via the microRNA-186-5p/CADM2 axis.

Qiu Q, Tan J Open Med (Wars). 2022; 17(1):1903-1914.

PMID: 36561840 PMC: 9730544. DOI: 10.1515/med-2022-0595.


Hypoxia ameliorates maternal diet-induced insulin resistance during pregnancy while having a detrimental effect on the placenta.

Sissala N, Myllymaki E, Mohr F, Halmetoja R, Kuvaja P, Dimova E Physiol Rep. 2022; 10(9):e15302.

PMID: 35535947 PMC: 9088222. DOI: 10.14814/phy2.15302.


Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia-Sumoylation-HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage.

Gusar V, Timofeeva A, Chagovets V, Kan N, Vysokikh M, Marey M Life (Basel). 2022; 12(1).

PMID: 35054494 PMC: 8780366. DOI: 10.3390/life12010101.


PM10 Alters Trophoblast Cell Function and Modulates miR-125b-5p Expression.

Chaiwangyen W, Pintha K, Tantipaiboonwong P, Nuntaboon P, Khantamat O, de Sousa F Biomed Res Int. 2022; 2022:3697944.

PMID: 35036432 PMC: 8759905. DOI: 10.1155/2022/3697944.


References
1.
Hromadnikova I, Kotlabova K, Hympanova L, Krofta L . Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res. 2015; 137:126-140. DOI: 10.1016/j.thromres.2015.11.032. View

2.
Ferracin M, Bassi C, Pedriali M, Pagotto S, DAbundo L, Zagatti B . miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Mol Cancer. 2013; 12(1):130. PMC: 4176119. DOI: 10.1186/1476-4598-12-130. View

3.
Wolfson G, Vargas E, Browne V, Moore L, Julian C . Erythropoietin and Soluble Erythropoietin Receptor: A Role for Maternal Vascular Adaptation to High-Altitude Pregnancy. J Clin Endocrinol Metab. 2016; 102(1):242-250. PMC: 5413104. DOI: 10.1210/jc.2016-1767. View

4.
McMullin M, White R, Lappin T, Reeves J, MacKenzie G . Haemoglobin during pregnancy: relationship to erythropoietin and haematinic status. Eur J Haematol. 2003; 71(1):44-50. DOI: 10.1034/j.1600-0609.2003.00085.x. View

5.
Steegers E, von Dadelszen P, Duvekot J, Pijnenborg R . Pre-eclampsia. Lancet. 2010; 376(9741):631-44. DOI: 10.1016/S0140-6736(10)60279-6. View